In a brief report published today in JAMA Cardiology, a team of pharmacists and clinicians at Beth Israel Deaconess Medical Center (BIDMC), part of Beth Israel Lahey Health, found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at increased risk of electrical changes to the heart and cardiac arrhythmias. The combination of hydroxychloroquine with azithromycin was linked to even greater changes compared to hydroxychloroquine alone.
- Arctic ocean expedition advances climate modeling
- Metoclopramide inhibits proliferation of leukemia stem cells
- UC study: The dangers of drugged driving are outpacing drunk driving
- Partners in crime: genetic collaborator may influence severity of the rare disease, NGLY1
- Life-threatening complications during pregnancy: greater long-term risk of death